Literature DB >> 16001088

Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effect.

E Paubelle, P Coppo, L Garderet, L Azizi, D Bories, N-C Gorin, L Fouillard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16001088     DOI： 10.1038/sj.leu.2403855

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  Pancreatic involvement by plasma cell neoplasms.

Authors:  Rodrigo Lopes da Silva
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 2.  How We Manage Patients with Plasmacytomas.

Authors:  Despina Fotiou; Meletios A Dimopoulos; Efstathios Kastritis
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 3.  Advances in the treatment of extramedullary disease in multiple myeloma.

Authors:  Yating Li; Zhengxu Sun; Xiaoyan Qu
Journal:  Transl Oncol       Date:  2022-06-06       Impact factor: 4.803

4.  Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance.

Authors:  Xiaoyan Qu; Lijuan Chen; Hairong Qiu; Hua Lu; Hanxin Wu; Hongxia Qiu; Peng Liu; Rui Guo; Jianyong Li
Journal:  Biomed Res Int       Date:  2015-04-23       Impact factor: 3.411

5.  Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma.

Authors:  Andrew C Tiu; Rashmika Potdar; Vivian Arguello-Gerra; Mark Morginstin
Journal:  Case Rep Hematol       Date:  2018-05-24

6.  A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.

Authors:  Meral Beksac; Guldane Cengiz Seval; Nicholas Kanellias; Daniel Coriu; Laura Rosiñol; Gulsum Ozet; Vesselina Goranova-Marinova; Ali Unal; Jelena Bila; Hayri Ozsan; Arben Ivanaj; Lejla Ibricevic Balić; Efstathios Kastritis; Joan Bladé; Meletios Athanasios Dimopoulos
Journal:  Haematologica       Date:  2019-07-05       Impact factor: 9.941

7.  Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor.

Authors:  Ying Wang; Aijun Liu; Tingting Xu; Jiahui Yin; Wenming Chen
Journal:  Clin Med Insights Oncol       Date:  2022-07-18

8.  Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT.

Authors:  Nico Gagelmann; Diderik-Jan Eikema; Simona Iacobelli; Linda Koster; Hareth Nahi; Anne-Marie Stoppa; Tamás Masszi; Denis Caillot; Stig Lenhoff; Miklos Udvardy; Charles Crawley; William Arcese; Clara Mariette; Ann Hunter; Xavier Leleu; Martin Schipperus; Michel Delforge; Pietro Pioltelli; John A Snowden; Maija Itälä-Remes; Maurizio Musso; Anja van Biezen; Laurent Garderet; Nicolaus Kröger
Journal:  Haematologica       Date:  2018-02-01       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.